Insider · CIK 0001744425
Pamela Esposito
Files at KYMR (Kymera Therapeutics, Inc.). First filing Dec 2, 2024, latest Dec 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KYMR: Kymera Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Kymera Therapeutics, Inc. | $2.3M 27,563 shares | -100% | +290% from low-13% from high | |
| 28Weak | Kymera Therapeutics, Inc. | $245k 5,000 shares | -100% | +107% from low-17% from high | |
| 10Weak | Kymera Therapeutics, Inc. | $123k 2,500 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +12,563 | $49.10 | $617k | 12,563 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +12,000 | $27.67 | $332k | 24,563 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,000 | $31.20 | $94k | 27,563 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -14,505 | $81.56 | $1.2M | 13,058 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -7,959 | $82.34 | $655k | 5,099 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,099 | $83.45 | $342k | 1,000 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $84.07 | $84k | 0 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,563 | $0.00 | $0 | 7,500 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Dec 17, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,000 | $0.00 | $0 | 13,000 | Dec 17, 2025 |
| Jun 25, 2025 | KYMR Kymera Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jun 26, 2025 |
| Jun 3, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $29.55 | $148k | 5,000 | Jun 3, 2025 |
| Jun 3, 2025 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $49.04 | $245k | 0 | Jun 3, 2025 |
| Jun 3, 2025 | KYMR Kymera Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 24,127 | Jun 3, 2025 |
| Dec 2, 2024 | KYMR Kymera Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,500 | $29.55 | $74k | 2,500 | Dec 2, 2024 |
| Dec 2, 2024 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,500 | $49.00 | $123k | 0 | Dec 2, 2024 |
| Dec 2, 2024 | KYMR Kymera Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 29,127 | Dec 2, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.